oncology partners logo
Successfully navigate the changing landscape of insurance and Medicare reimbursements.  
Chemotherapy Medication Management
Oncology Partners Home page link
link to About Oncology Partners
link to Oncology Partners Services page
link to Billing page
Chemo Medication Management page
link to Practice Planning page
Career position listings with Oncology Partners
Contact Oncology Partners

Administering chemotherapy and other infusion agent-related procedures is the cornerstone of an oncology practice’s income. This dependence on chemotherapy-related income presents a unique problem to oncology practices in today’s insurance reimbursement environment. Gone are the days of high returns on chemotherapy medications – today’s insurance and Medicare payouts more closely match a practice’s original infusion agent costs. Inaccuracies in chemotherapy medication inventory can lead to the largest profit losses for oncology practices as failure to record administering an infusion agent costs the practice much more than not collecting on an office visit.

The most straightforward ways for oncology practices to get ahead is to pay less for the chemotherapy medications in the first place and accurately record infusion agent inventories. But how?

Oncology Partners works on our clients’ behalf to negotiate lower infusion agent prices with manufacturers, wholesalers and managed care organizations (MCOs), saving clients money, time and frustration. We also offer growth area analysis to identify and capitalize on the most profitable regimens a practice administers. The savings on supplies is coupled with chemotherapy agent inventory management to help oncology practices ensure that all infusion agents administered are accounted for.

Adding Oncology Partners’ billing services to our chemotherapy medication management services can help oncology practices further capitalize on savings and increased income to raise profits. Our billing experts maintain a list of the most current infusion agent and valid diagnosis codes, and they pre-authorize treatment to further shorten reimbursement time.

These proven methods work in tandem to help oncology practices of all sizes and insurance mixes navigate the changing insurance reimbursement landscape.